Endovascular management of renal angiomyolipomas: Do coils have a benefit in terms of clinical success rates?
Open Access
- 21 December 2022
- journal article
- research article
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (6) , 597-602
Abstract
This study evaluated single-center results of endovascular treatment in renal angiomyolipoma (AML) to determine whether there is clinical relevance of adding proximal coil embolization to distal particle embolization in terms of safety, efficacy, and retreatment rates. A retrospective analysis was performed to evaluate patients undergoing transarterial embolization for renal AMLs from January 2007 to October 2020. Parameters regarding patient and tumor characteristics, embolization technique, treatment outcome, and complications were recorded. Patients were divided into 2 groups as A (only particle group) and B (particle + coil group) based on the type of embolic agent used for treatment. Comparative analysis was performed between the 2 groups in terms of tumor size reduction, retreatment, and complication rates. In this study, 42 patients (37 (88.1%) females and 5 (11.9%) males) harboring 48 AMLs were included. The mean age was 43.46 (range, 20-78). The technical success rate was 95.8% (46 of 48 procedures). The mean size reduction was 1.94 ± 1 cm (P < .001) after treatments; however, no significant difference was seen between groups in terms of tumor size reduction. Retreatment rates were 3.1% (1 of 32 cases) in group A and 14.3% (2 of 14 cases) in group B (P = .21). No significant difference was found between groups in terms of bleeding and complication rates during the perioperative period. Mean follow-up duration was 26.48 ± 25.71 (range, 2-102) months. In this study, no clear supplementary benefit was observed in terms of safety and efficacy with the adjunction of coils to distal particle embolization in the management of AMLs.Keywords
This publication has 29 references indexed in Scilit:
- Selective Arterial Embolization of Angiomyolipomas: A Comparison of Smaller and Larger Embolic AgentsJournal of Urology, 2011
- Contemporary Experience in the Management of AngiomyolipomaJournal of Endourology, 2010
- Effects of Repeat Bolus Ethanol Injections on Cardiopulmonary Hemodynamic Changes during Embolotherapy of Arteriovenous Malformations of the ExtremitiesJournal of Vascular and Interventional Radiology, 2010
- Fatal Nontarget Embolization via an Intrafibroid Arterial Venous Fistula during Uterine Fibroid EmbolizationJournal of Vascular and Interventional Radiology, 2009
- Prediction of the Effect of Injected Ethanol on Pulmonary Arterial Pressure during Sclerotherapy of Arteriovenous Malformations: Relationship with Dose of EthanolJournal of Vascular and Interventional Radiology, 2009
- Embolization of renal angiomyolipoma: immediate complications and long-term outcomesClinical Radiology, 2008
- Renal artery embolization: clinical indications and experience from over 100 casesBJU International, 2006
- LONG-TERM OUTCOME OF TRANSCATHETER EMBOLIZATION OF RENAL ANGIOMYOLIPOMAS DUE TO TUBEROUS SCLEROSIS COMPLEXJournal of Urology, 2005
- Renal Angiomyolipoma: Long-term Results after Arterial EmbolizationJournal of Vascular and Interventional Radiology, 2005
- Fatal Pulmonary Complications after Arterial Embolization with 40–120-μm Tris-acryl Gelatin MicrospheresJournal of Vascular and Interventional Radiology, 2004